Wellisen Nutraceuticals is a celebrated nutraceuticals and personal care company that is redefining health and beauty for people. Established in 1999, it is the second largest manufacturer of Spirulina in India. Situated in Mysore city in South India, the company's state-of-the-art manufacturing facility spans 45 acres and is dedicated to cultivating Spirulina in 12 open lined ponds under strict hygienic control, free from herbicides, pesticides, or any runoff contamination. The Spirulina is grown, harvested, spray dried, and processed by a team of experienced and trained staff, ensuring it is 100% organic and of premium quality. Wellisen Nutraceuticals collaborates closely with the Central Food Technological Research Institute (CFTRI) and other global research institutes to consistently achieve GMP standards for its products. Currently, the production capacity stands at 9 tons of Spirulina per month. The company operates in the Health Care and Manufacturing sectors, with its headquarters located in India. Overall, Wellisen Nutraceuticals has solidified its position as a prominent player in the nutraceuticals and personal care industry. With its commitment to quality, organic practices, and strategic collaborations with renowned research organizations, the company is well-positioned to meet the increasing demand for premium Spirulina products in the global market. While information regarding the last investment and investors is not available at the moment, Wellisen Nutraceuticals' strong foothold in the industry and dedication to excellence make it an appealing prospect for potential investors looking to capitalize on the growing health and wellness sector.
There is no investment information
No recent news or press coverage available for Wellisen Nutraceuticals.